Updated Nov. 3, 2011 at 6:54 a.m.

Premium Lock GSK to pay US $3B to settle probes of sales, marketing

Published: 2011-11-03 06:44:00
Updated: 2011-11-03 06:54:15

Andrew Witty  Andrew Witty Image 1 of 2 · Next Image…

The case dates from 2004, and includes investigations of possible price irregularities and the development and marketing of the diabetes drug Avandia. One analyst says the deal removes "uncertainty" about "ongoing legal issues."...

Read More
Read More

Copyright 2014 WRAL TechWire and the Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll